These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22492511)

  • 1. Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene.
    Mitra P; Pereira LA; Drabsch Y; Ramsay RG; Gonda TJ
    Nucleic Acids Res; 2012 Jul; 40(13):5988-6000. PubMed ID: 22492511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.
    Ogba N; Chaplin LJ; Doughman YQ; Fujinaga K; Montano MM
    Cancer Res; 2008 Sep; 68(17):7015-24. PubMed ID: 18757415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers.
    Sengupta S; Biarnes MC; Jordan VC
    Breast Cancer Res Treat; 2014 Jan; 143(1):113-24. PubMed ID: 24309997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
    Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).
    Qi T; Tang W; Wang L; Zhai L; Guo L; Zeng X
    J Biol Chem; 2011 Apr; 286(17):15171-81. PubMed ID: 21378166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-TEFb is a crucial co-factor for Myc transactivation.
    Gargano B; Amente S; Majello B; Lania L
    Cell Cycle; 2007 Aug; 6(16):2031-7. PubMed ID: 17700062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z; Reierstad S; Huang CC; Bulun SE
    Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat.
    Brès V; Gomes N; Pickle L; Jones KA
    Genes Dev; 2005 May; 19(10):1211-26. PubMed ID: 15905409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.
    Albert TK; Antrecht C; Kremmer E; Meisterernst M
    PLoS One; 2016; 11(1):e0146648. PubMed ID: 26745862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle dependent oscillatory expression of estrogen receptor-α links Pol II elongation to neoplastic transformation.
    Vantaggiato C; Tocchetti M; Cappelletti V; Gurtner A; Villa A; Daidone MG; Piaggio G; Maggi A; Ciana P
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9561-6. PubMed ID: 24979764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.
    Mitra P; Yang RM; Sutton J; Ramsay RG; Gonda TJ
    Oncotarget; 2016 Feb; 7(8):9069-83. PubMed ID: 26812885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.
    Jang MK; Mochizuki K; Zhou M; Jeong HS; Brady JN; Ozato K
    Mol Cell; 2005 Aug; 19(4):523-34. PubMed ID: 16109376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive transcription elongation factor b (P-TEFb) contributes to dengue virus-stimulated induction of interleukin-8 (IL-8).
    Li LL; Hu ST; Wang SH; Lee HH; Wang YT; Ping YH
    Cell Microbiol; 2010 Nov; 12(11):1589-603. PubMed ID: 20618343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of P-TEFb by the MEK1-extracellular signal-regulated kinase signaling pathway contributes to stimulated transcription elongation of immediate early genes in neuroendocrine cells.
    Fujita T; Ryser S; Piuz I; Schlegel W
    Mol Cell Biol; 2008 Mar; 28(5):1630-43. PubMed ID: 18086894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
    Duplessis TT; Williams CC; Hill SM; Rowan BG
    Endocrinology; 2011 Jun; 152(6):2517-26. PubMed ID: 21505052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.